$6.50
-0.17[-2.55%]
Last update: 9:29AM Get Real Time Here
Health Catalyst
(NASDAQ:HCAT)Latest News for Health Catalyst Stock (NASDAQ:HCAT)
Health Catalyst Stock (NASDAQ: HCAT)
Categories: All
Thursday, May 09, 2024
- Health Catalyst Sees FY24 Revenue $304.0M-$312.0M Vs $308.685M Est.Benzinga Newsdesk - 17 hours ago
- Health Catalyst Sees Q2 2024 Revenue $73.5M-$76.5M Vs $75.554M Est.Benzinga Newsdesk - 17 hours ago
- Health Catalyst Q1 2024 Adj EPS $0.05 Beats $0.03 Estimate, Sales $74.723M Miss $74.802M EstimateBenzinga Newsdesk - 18 hours ago
Wednesday, April 10, 2024
- What 7 Analyst Ratings Have To Say About Health CatalystBenzinga Insights - Apr 10, 2024, 11:00AM
- Cantor Fitzgerald Reiterates Overweight on Health Catalyst, Maintains $16 Price TargetBenzinga Newsdesk - Apr 10, 2024, 10:16AM
- SMART Global Reports Q2 Results, Joins Health Catalyst And Other Big Stocks Moving Lower In Wednesday's Pre-Market SessionAvi Kapoor - Apr 10, 2024, 5:57AM
- Keybanc Downgrades Health Catalyst to Sector WeightBenzinga Newsdesk - Apr 10, 2024, 4:44AM
Tuesday, March 05, 2024
Monday, February 26, 2024
Friday, February 23, 2024
- Health Catalyst shares are trading lower after the company reported Q4 financial results and issued Q1 and FY24 revenue guidance below estimates. Also, Canaccord Genuity maintained a Buy rating on the stock but lowered its price target from $12 to $11.Benzinga Newsdesk - Feb 23, 2024, 12:01PM
- Analyst Scoreboard: 5 Ratings For Health CatalystBenzinga Insights - Feb 23, 2024, 10:00AM
- Canaccord Genuity Maintains Buy on Health Catalyst, Lowers Price Target to $11Benzinga Newsdesk - Feb 23, 2024, 9:44AM
Thursday, February 22, 2024
- Health Catalyst Sees FY24 Revenue $304M-$312M Vs $324.489M Est.Benzinga Newsdesk - Feb 22, 2024, 4:39PM
- Health Catalyst Sees Q1 2024 Revenue $72.5M-$76.5M Vs $78.989M Est.Benzinga Newsdesk - Feb 22, 2024, 4:39PM
- Health Catalyst Q4 2023 GAAP EPS $0.02, Sales $75.08M Beat $73.60M EstimateBenzinga Newsdesk - Feb 22, 2024, 4:15PM
- Earnings Scheduled For February 22, 2024Benzinga Insights - Feb 22, 2024, 5:27AM
Wednesday, February 21, 2024
Friday, January 26, 2024
Tuesday, January 09, 2024
Monday, January 08, 2024
Wednesday, January 03, 2024
Friday, December 22, 2023
Wednesday, December 13, 2023
- Expert Ratings for Health CatalystBenzinga Insights - Dec 13, 2023, 3:00PM
- D.R. Horton To Rally Around 19%? Here Are 10 Top Analyst Forecasts For WednesdayAvi Kapoor - Dec 13, 2023, 7:44AM
- JP Morgan Upgrades Health Catalyst to Overweight, Lowers Price Target to $11Benzinga Newsdesk - Dec 13, 2023, 6:10AM
Monday, November 13, 2023
- Health Catalyst shares are trading higher after Piper Sandler upgraded the stock from Neutral to Overweight.Benzinga Newsdesk - Nov 13, 2023, 12:04PM
- HP To Rally Around 20%? Here Are 10 Top Analyst Forecasts For MondayLisa Levin - Nov 13, 2023, 8:32AM
- Where Health Catalyst Stands With AnalystsBenzinga Insights - Nov 13, 2023, 7:00AM
- Piper Sandler Upgrades Health Catalyst to Overweight, Lowers Price Target to $11Benzinga Newsdesk - Nov 13, 2023, 4:53AM
Wednesday, November 08, 2023
Thursday, November 02, 2023
Wednesday, November 01, 2023
Monday, October 30, 2023
Friday, October 27, 2023
Wednesday, October 25, 2023
Monday, October 16, 2023
Thursday, September 14, 2023
Tuesday, August 29, 2023
Tuesday, August 08, 2023
Tuesday, August 01, 2023
Tuesday, June 27, 2023
Wednesday, May 10, 2023
- Health Catalyst's Q1 Earnings: Analysts Diverge on Outlook as Company Faces Demand Headwinds and Revenue OutperformanceVandana Singh - May 10, 2023, 2:33PM
- RBC Capital Maintains Sector Perform on Health Catalyst, Lowers Price Target to $13Benzinga Newsdesk - May 10, 2023, 11:27AM
- Benzinga's Top Ratings Upgrades, Downgrades For May 10, 2023Benzinga Insights - May 10, 2023, 11:00AM
- Health Catalyst shares are trading lower after the company reported Q1 financial results and issued guidance.Benzinga Newsdesk - May 10, 2023, 8:56AM
- Raymond James Downgrades Health Catalyst to Market PerformBenzinga Newsdesk - May 10, 2023, 7:31AM